Publications by authors named "M Santero"
Objectives: To assess the associations between cost-effectiveness analysis' (CEA) methodological characteristics and incremental cost-effectiveness ratio outcomes and conclusions, in biological treatments for asthma.
Study Design And Setting: We included CEAs comparing biological treatments to standard care, in adults with severe asthma. We performed a search in MEDLINE, EMBASE, and Web of Science (September 2022).
Introduction: In high-income countries, quality improvement interventions and research are usually guided by trauma registries. In low- and middle-income countries, the implementation of trauma registries has been limited mainly for cost reasons.
Objective: To analyze the budgetary impact of the implementation of trauma registries in Argentina.
Article Synopsis
- - The study aimed to evaluate how well osteoporosis Clinical Practice Guidelines (CPGs) for preventing fractures in postmenopausal women incorporated patient perspectives during their development.
- - Out of 491 guidelines reviewed, only 24.2% included individual viewpoints, with low average quality scores in areas like applicability and stakeholder involvement, highlighting insufficient patient representation.
- - Results showed that higher quality guidelines tended to include women’s perspectives more, indicating a need for improvement in incorporating these views in guideline development for osteoporosis prevention.
Background: Highlighting the identified gaps in evidence-based research concerning advanced esophageal cancer (EC) treatment and care, this review evaluates the efficacy and safety of anticancer drugs compared to supportive care for advanced EC patients, aiming to assess the appropriateness of usual treatments and identify the gaps that need to be filled with primary research.
Methods: We searched (May 2022) MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Epistemonikos, and trial registries (ClinicalTrials.gov and PROSPERO) for randomised controlled trials (RCTs) comparing anticancer drugs (chemotherapy, immunotherapy, or biological/targeted therapy) with supportive care in advanced EC.
Aim: To assess the appropriateness of systemic oncological treatments (SOT) provided to patients diagnosed with advanced esophageal cancer (EC) across a group of participating hospitals.
Methods: Multicenter, retrospective cohort study in five Spanish hospitals including newly confirmed advanced EC cases between July 1, 2014, and June 30, 2016, with a 5-year follow-up.
Results: We identified 157 patients fulfilling the inclusion criteria (median age: 65 years, 85.